Your browser doesn't support javascript.
loading
Fertility preservation in pediatric and adolescent cancer patients in Switzerland: A qualitative cross-sectional survey.
Diesch, Tamara; von der Weid, Nicolas Xavier; Szinnai, Gabor; Schaedelin, Sabine; De Geyter, Christian; Rovó, Alicia.
Afiliación
  • Diesch T; University Children's Hospital Basel, Division of Pediatric Oncology/Hematology, Basel, Switzerland. Electronic address: Tamara.Diesch@ukbb.ch.
  • von der Weid NX; University Children's Hospital Basel, Division of Pediatric Oncology/Hematology, Basel, Switzerland.
  • Szinnai G; University Children's Hospital Basel, Department of Pediatric Endocrinology, Basel, Switzerland.
  • Schaedelin S; University Hospital Basel, Clinical Trial Unit, Basel, Switzerland.
  • De Geyter C; University Hospital Basel, Clinic of Gynecological Endocrinology and Reproductive Medicine, Basel, Switzerland.
  • Rovó A; University Hospital Bern, Department of Hematology, Bern, Switzerland.
Cancer Epidemiol ; 44: 141-146, 2016 10.
Article en En | MEDLINE | ID: mdl-27592062
ABSTRACT
Fertility preservation (FP) is an important topic of discussion in the field of oncology, particularly in pediatric oncology. Despite the awareness of severe impact of infertility on quality of life and different guidelines available in this area, the options in FP are not routinely discussed with the pediatric cancer patients and their parents. To the best of our knowledge, this is the first survey report concerned to FP counseling and procedures in pediatric and adolescent cancer patients in Switzerland. This survey was conducted from June 2014 to October 2014 on the counseling and procedures performed between 2009 and 2013; the questionnaire was completed by one of the professional from hematology/oncology centers in Switzerland. Currently, only four out of nine centers have a program for FP. In 2013, 45/301 (15%) patients received FP counseling and 36/301 (12%) underwent an FP procedure. The most commonly performed procedures from 2009 to 2013 were administration of gonadotropin releasing hormone agonist (3%) and cryopreservation of ovarian tissue in females (3%) and cryopreservation of sperms in males (6%); the most frequently cited reason for the absence of FP counseling was lack of time (55%). Therefore, this survey should help to develop and harmonize practices with respect to FP counseling and procedures in Switzerland, and to establish FP as a standard of care during cancer treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Comunicación en Salud / Preservación de la Fertilidad / Infertilidad / Neoplasias Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Cancer Epidemiol Asunto de la revista: EPIDEMIOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Comunicación en Salud / Preservación de la Fertilidad / Infertilidad / Neoplasias Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Cancer Epidemiol Asunto de la revista: EPIDEMIOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article